Minaris Regenerative Medicine
William Burckardt is an experienced financial executive currently serving as the Chief Financial Officer for North America at Minaris Regenerative Medicine since September 2016. In addition to this role, William also holds the position of Senior Director of Finance at Hitachi Chemical Advanced Therapeutics Solutions, LLC, starting in September 2016. Prior to these roles, William was the Director of Accounting at RestorixHealth from September 2013 to August 2016 and served as a Senior Accountant at Frontier Communications from September 2012 to September 2013, as well as at O'Connor Davies, LLP from June 2007 to September 2012. William earned a Bachelor of Science degree in Accounting from Manhattan University, where studies were completed between 2003 and 2007.
This person is not in any offices
Minaris Regenerative Medicine
Minaris Regenerative Medicine is a global contract development and manufacturing organization for the production of cell and gene therapy products. We offer our clients clinical and commercial manufacturing services, development solutions, and technologies. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. At Minaris, we are creating cell therapy miracles together. Minaris Regenerative Medicine is wholly owned by the Resonac Group.